NCT02744625View on ClinicalTrials.gov

Physiologic Study of Cerebral Perfusion

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Cerebral Perfusion PressureVasopressor AgentsShockMagnetic Resonance Imaging (MRI), Functional
Interventions
DRUG

Higher doses of vasopressor therapy for a MAP of 75 mmHg

DRUG

Lower doses of vasopressor therapy for a MAP of 65 mmHg

DRUG

Propofol for light sedation

Propofol for light sedation

Trial Locations (1)

J1H 5N4

Université de Sherbrooke, Sherbrooke

All Listed Sponsors
lead

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

OTHER

NCT02744625 - Physiologic Study of Cerebral Perfusion | Biotech Hunter | Biotech Hunter